Moreover, functionally CCL3 acts as a downstream target of piR-57125 where piR-57125 binds to CCL3 directly and inhibits ccRCC metastasis by down-regulating the AKT/ERK axis. This evidence concerns the gene CCL3 and nonpapillary renal cell carcinoma.